Contact Us     Privacy     Terms of Use                                                                © Copyright Pharma Market Research Conference 2011.  All Rights Reserved.
Day 1, Wednesday, February 4, 2015
General Session:
7:15 - 8:15
Registration & Networking Breakfast in Exhibition Hall
_______________________________________________________________________________________
8:15 - 8:30
Chairpersons’ Opening Remarks
_______________________________________________________________________________________
8:30 - 9:10
Keynote: Unlocking Brand Potential: A Patient-Centric Approach
Jon Congleton
, Senior Vice President & General Manager, Global CNS, Teva
_______________________________________________________________________________________
9:10 - 9:50
Keynote: Topic TBA
TBA

_______________________________________________________________________________________
9:50 - 10:50
Networking & Refreshments in Exhibition Hall
_______________________________________________________________________________________
10:50 - 11:30
Reaction to Keynote Presentations By Advisory Board Members
Praveen Advani
, Executive Director, Customer Insights Oncology - IO, Bristol-Myers Squibb
Lisa Courtade, Executive Director, Global Market Research Excellence, Merck
Sandipa Dublish, Sr. Director Global MR, Alexion Pharmaceuticals
Steve Girling, President, Ipsos Healthcare
Stuart Greenberg, Deputy Director, Global/Oncology Market Research, Bayer
Anne Hale, US Specialty Care Lead – Business Analytics & Insights, Pfizer
Grace Samoil Reynolds, Head Market Insights, Celgene
David Rosen, Executive Director, Forecasting, Analytics & Market Research, Purdue Pharmaceuticals
_______________________________________________________________________________________
11:30 - 12:20
Networking Roundtable Discussions
ROUNDTABLE 1
Opportunities in Global Market Research
Frank Wang
, Senior Director, Global Business Insights Oncology, EMD Serono
ROUNDTABLE 2
“Do It Yourself” Analytics
Wasse Alemayehu
, Director, Shire Pharmaceuticals
ROUNDTABLE 3
What Truly Drives Physicians Behavior Beyond Efficacy and Safety of the Products and How Does
One Go About Diving Deeper Behind the Veil?
Aaron Furtado
, Senior Director, Business Planning, Market Research, & Business Analytics, Ipsen
ROUNDTABLE 4
Topic TBA
John Vieira
, Sr. Director, Global Brand Strategy, Daiichi Sankyo
ROUNDTABLE 5
Challenges in Global Forecasting
Suraj Moorthy
, Senior Director, Global Forecasting, EMD Serono
ROUNDTABLE 6
Topic TBA
Carolyn Kreusser
, Associate Director, Auxilium
ROUNDTABLE 7
Topic TBA
Michael McClellan,
Associate Director, Global New Products Market Research, Eisai
ROUNDTABLE 8
TBA
   
12:20 - 1:35
Networking Luncheon
_______________________________________________________________________________________
1:40 - 2:15
Participants may choose 1 of 4 concurrent tracks.
TRACK A
Performance of Biosimilars in Key Markets and Innovator Defense Strategies
Rich McCloud
, Director, Pfizer

•        What is the penetration rate of Biosimilars in key markets?
•        In more detail, how is the first MaB peforming in Europe over time?
•        What are some of the innovator defense strategies that are employed to defend market share?
_______________________________________________________________________________________
TRACK B
Successful Strategic Decision-Making Frameworks for Development Compounds Using a Zero
Research Model
Steve Girling
, President, Ipsos Healthcare
Client Co-Presenter TBA
_______________________________________________________________________________________
TRACK C
Global Online Patient Communities 2015 – Technology Spread and Experience Have Made This
Possible
Donna Simpson
, Principal, Segmedica
Michelle Soto, Senior Project Director, Segmedica
_______________________________________________________________________________________
TRACK D
Big Data Analytics in the Pharmaceutical Industry: Leading the Analytics Revolution
Abhilash Davé, PhD
, Principal, Strategic Research Insights, Inc. (SRI)
Sudhakar Mandapati, Principal, Strategic Research Insights, Inc. (SRI)
Client Co-Presenters TBA

Strategic Research Insights is aggressively leading the analytics revolution in the Pharmaceutical and Biotech
Industry utilizing Big Data (EMR, Claims, Registry) for multiple clients, and has been nominated for awards.
The presentation identifies some of the best practices in Big Data Analytics. Additionally, the authors highlight
key metrics that can be easily gleaned from EMR and Claims data to successfully measure product
performance. Another major advance is identification of opportunities and leverage points predictive modeling.
The research will be presented with one or more clients.
_______________________________________________________________________________________
   
2:20 - 2:55
Participants may choose 1 of 4 concurrent tracks.
TRACK A
Product Launch and the MR Needed – Understanding the “Behind the Scenes” as a Tool to Deliver
the Winning Proposal
Magda Schoeneich
, Associate Director Insights Generation Neuroscience, Janssen
_______________________________________________________________________________________
TRACK B
The Moment is the Medium: Human-Centric Research in the Digital Age
Sal Zerilli
, Knowledge Architect, in-sync
Jedd Davis, SVP, Media, Publicis Health Media
Client Co-Presenter TBA

The past two decades of digital media innovation have caused fundamental changes in marketing across all
industries, including healthcare. These changes have pressured Market Researchers on both sides of the
client-supplier relationship to rethink the kinds of methods we use, the kinds of data we pursue, and the roles
we play for our employers and within the industry. In today’s media environment, change and complexity define
the new normal for all of us. Unenviably, we often need to cope with change and complexity by doing more with
less. Ugh. In this session, a supplyside researcher (in-sync) and a media strategist (Publicis Health Media) will
co-present a case study of how we successfully responded to these dynamics by leveraging “old” research
methods and social science ideas to disrupt and improve the media planning process for one of the largest
healthcare brands in the world. We will walk the audience through a blinded review of our process,
emphasizing five factors that were essential to our success: (1) focusing on moments where human-centric
and business-centric needs intersect, (2) re-thinking and re-using “old” ideas and methods for “new”
purposes, (3) employing multidisciplinary teams, (4) integrating qual-quant methods, and (5) developing
supplier client partnerships in Research and Development efforts to solve complex problems endemic to the
“digital age.”
_______________________________________________________________________________________
TRACK C
Are You My Patient? Using Patient Trigger Studies to Determine if Your Messaging is On Target
Katy Palmer
, Managing Director, Healthcare, Market Strategies
_______________________________________________________________________________________
TRACK D
Co-Constructing the Ideal Doctor-Patient Dialogue: Bridging the Gaps Between KOL Best Practices
and Community-Level Realities
Kaity Arctander
, Senior Analyst, Linguistic Insights and Analytics, Verilogue
Jeff Troy, Director, Client Services, Verilogue

All pharmaceutical brands employ a partnership with Key Opinion Leaders (KOLs) to inform their strategies
throughout the product lifecycle. While these advisory boards provide a wealth of real-world knowledge and
insights about the marketplace, they further highlight the vast gap that exists between the communication
tactics and interaction styles of KOLs versus busy community-level physicians. In this session you will learn
about a unique engagement encompassing Advisory Board listening workshops focused on community-level
interactions, linguistic analysis of KOL-Patient dialogue recordings, and strategic development of physician
and patient communication tools. This success story divulges the “secret sauce” of how to leverage KOLs as
mentors to community physicians by co-constructing the ideal conversational flow.
_______________________________________________________________________________________
   
3:00 - 3:35
Participants may choose 1 of 4 concurrent tracks.
TRACK A
Dimensions: A Better, More Efficient Route to Improving Your ROI- Greater Customer
Understanding by Identifying Their Unmet Needs
Mitchel Horowitz
, Methodologist, Partner, Lieberman
Sabera Hyderally, EVP, Lieberman
Elaine Melilo, Manager, Global Customer Insights Surgical Solutions, Covidien

Lieberman’s Dimensions methodology pinpoints the relative desirability of individual features and feature
combinations at a price. While it has elements in common with standard preference modeling techniques like
SIMALTO, Dimensions is pragmatically focused on the vital “hierarchy of preferences” necessary for a
successful launch or restage. With Dimensions, market efforts can be calibrated to perfectly match real world
preferences.
_______________________________________________________________________________________
TRACK B
Brand Improv: Creating Strategic Empathy for Brand Teams
Steve Martino
, Co-Managing Partner, M Health
John Surie, Customer Insight Director, M Health

Brand Improv is a novel workshop technique that uses actors to literally bring research findings to life in order
to help brand teams recognize new strategic opportunities hidden in the research they commission.  

Brand Improvs are usually given in rented theatre space as one-day research-to-strategy workshops involving
a small team of researchers, brand marketers and professional actors. The actors, who are carefully prepped
in advance, translate a defined set of market research insights into flesh-and-blood scenarios that unfold right
before the eyes of the brand team. The idea is to make the insights as experiential as possible in order to
create strategic empathy. That is, enabling strategists to feel what their customers feel. By then guiding the
brand team through well-structured ideation exercises, the research insights and the improvisations that bring
them to life act as powerful stimuli for break-through strategic thinking.
_______________________________________________________________________________________
TRACK C
Good Guidelines, Bad Guidelines:  Why, When, and How Payers Decide to Adopt or Ignore
Guidelines in Setting Formularies and Utilization Management Policies
Roger Green
, President/CEO, RG+A
Robert Kritzler, M.D., Deputy Chief Medical Officer, Care Management, Johns Hopkins HealthCare LLC

Historically, healthcare stakeholders have viewed treatment guidelines as one path to assuring consistent
application of high-quality healthcare. In theory, utilizing guidelines guarantees excellent care and a positive
cost-benefit profile.In practice, it has never been this simple. Development and enforcement of appropriate
guidelines have always presented significant challenges to healthcare systems and insurers. Over the past
year, the issues has become more challenging, as an explosion of specialty drug spending has made it
impossible for health systems to afford therapies that might prove cost-beneficial in the long run.

Against this background, the application of guidelines has become increasingly controversial and inconsistent.
 Some professional societies have begun to promulgate cost-sensitive guidelines. At the same time, some
insurers claim that they will create or support guidelines that focus even more strongly on cost management in
specialty pharmaceuticals. In this session, Dr. Kritzler and Mr. Green will report on a series of on-line bulletin
boards conducted with payers nationwide that address changing perspectives and use regarding guidelines,
and a study evaluating current utilization trends. Also, they will discuss how developments in HCV and
multi-specialty agent regimens in oncology and hematology are reshaping how health plans monitor and
manage these categories.
______________________________________________________________________________________
TRACK D
Leveraging EMR Data to Better Understand Local Market Potential and the Deployment of
Commercial Resources
Jim Charnetski
, Practice Lead, Commercial Analytics & Effectiveness, Quintiles

Historically, EMR and HEOR data has resided within the clinical side of pharma organizations. However,
commercial organizations are beginning to adopt and leverage this information in the commercial space to
drive decisions around disease state market potential, patient and physician targeting, treatment
pathway/patient journey insights, and the local deployment of commercial resources. A key focus point of this
approach is the ability to understand the degree to which local geographies are adopting preferred disease
management protocols for given disease states and defined patient cohorts. Through this analytical approach,
clients can identify areas where a “treatment deficit” exists relative to the established standards, and deploy
greater education and resource activities against these geographies to reduce that gap and deliver greater
health outcomes to patients.
_______________________________________________________________________________________
   
3:35 - 4:35
Networking & Refreshments in Exhibition Hall
_______________________________________________________________________________________
4:35 - 5:10
Participants may choose 1 of 4 concurrent tracks.
TRACK A
The Human Truth Behind Health Management: How Merck Leveraged Social Psychology and
Behavioral Economics to Inspire Experience Design
Anna Kravets
, Director, External Partner Platform, Merck

Merck sought to drive deep consumer empathy across the entire organization and brand portfolio. Despite
having access to a treasure trove of data outlining consumers' rational perspectives and behaviors around
health, Merck recognized that they needed to know more about the underlying psychological motivations that
drive decisions to be either proactive or reactive regarding managing one's health. The Merck team knew that
building an understanding of the roles various dimensions and tools play in health management decisions
would enable the development of design personas that inform key strategic decisions, M&A, and new business
model exploration.
This presentation will reveal:
•        How Merck gained a clearer perspective on consumers through uncovering non-conscious drivers
•        How understanding the consumer journey brings meaningful design opportunities into view
•        How building consumer empathy internally can bring clarity to business objectives
•        How understanding consumers' value orientations and personality traits can inspire personas to fuel
experience design
_______________________________________________________________________________________
TRACK B
Maximizing Messaging Utility
Michael Heasley
, Partner and Chief Research Officer, Evolution Consulting
Krystyna Litton, Consultant, Evolution Consulting

Through the analysis of historic data and the application of marketing theory, it is possible to determine a set
of related functions that describes both the Value and the Impact of a product’s message over time.  We will
review the theory, closely examine a case-study that shows this model in action, and discuss ways to make this
theory actionable to your or your customer’s brand.
_______________________________________________________________________________________
TRACK C
Glass Half Full or Half Empty: How Google Glass Gave Insight in Landmark Healthcare Market
Research Study
Katy Irving
, Associate Director, HRW

There is a lot of hype around wearable technology, but what does it really deliver for market research?  In this
presentation, HRW will showcase the results from a first-of-its-kind series of adapted ethnography research
projects conducted with physicians and patients using Google Glass; and how this allowed us to literally see
things from our participants’ perspective.  
The session will:
•        Introduce the uninitiated to Google Glass ‘in the flesh’ and demonstrate its multi-method data capture
•        Offer an honest review of the unique benefits and limitations of Glass from our experience with real
respondents
•        Discuss how it compares with other methods (both ‘traditional’ and digital)
•        Highlight where/how it is best utilized to add value and share feedback from pharma clients on the impact
it has had for them
______________________________
_________________________________________________________
TRACK D
Top Chef: Eight Ingredients to Being Indispensable
Rayna Herman
, Principal, SVP Sales and Marketing, Health Strategies Group

Answering member’s requests for a topic on the strategic leader’s role & fostering strategic partnerships, this
workshop will provide a proven recipe that empowers market researchers to move from data providers into
business savvy advisors, strategically anticipating the needs of their internal customers and championing a
market research plan that generates product success. Participants will leave this hands-on workshop feeling
confident and empowered to expand their role using a cutting-edge eight-step process that provides
actionable principles to unlock greater levels of growth, innovation, and success for them. Each step identifies
specific actions they can adopt to immediately increase:
•         their ability to foresee the business needs of the team long before the rest of the team realizes them,
•         the level of reliance their internal stakeholders have on them, and
•         the team's perception of them as vital strategic leaders rather than reactive data providers.
_______________________________________________________________________________________
   
5:15 - 6:15
Participants may choose 1 of 4 concurrent tracks.
TRACK A
Social Media Listening
Moderator: Lisa Courtade, Executive Director, Global Market Research Excellence, Merck
Marjorie Reedy, Director, Global Market Research & Analytics, Merck
Additional Panelists TBA
_______________________________________________________________________________________
TRACK B
Evolving Role of a Market Researcher in a Time of Change
Terri Boyd
, Procurement, Market Research, Janssen
Ted Finlay, Director of Market Research & Statistical Analysis, Merial
Kumar Kantheti, Senior Director, Portfolio Management, Global Development Division, Shionogi Inc
Anindita Niyogi, Director, Market Analytics - Specialty Care, Pfizer
Pamela Posnock, Director-Oncology Global Market Research & Analytics, Merck
_______________________________________________________________________________________
TRACK C
De-Mystifying Franchise Strategy - How Pragmatic Approaches Can Help Brand Teams Prioritize and
Win Whether They Are the Dominant Incumbent or the New Kid on the Block
Moderator: Chris Schneider, SVP, Commercial Strategy and Forecasting, Ipsos Healthcare
Additional Panelists TBA
_______________________________________________________________________________________
TRACK D
Industry and Agency Interaction Best Practices
Moderator: Rafaat Rahmani, President, Lifescience Dynamics
Renata Alves, Sr. Manager, Business Analytics and Insights, Pfizer
Suraj Moorthy, Senior Director, Global Forecasting, EMD Serono
Mini Pinto, Global Customer Insights Director, Merck
Timothy Subotkowski, Senior Manager Global Market Research, Alexion

This symbiotic relationship with agency and industry will improve the chances of successful MR projects with
positive ROI, protect our profession from data fetchers. Therefore, we all as MR professional should aspire to
be the extended team of our clients.
______________________________________________________________________________________
   
6:15 - 8:00
Evening Socializing Events! Casino Gaming, Reception & Networking
_______________________________________________________________________________________
   
Day 2, Thursday, February 5, 2015
7:15 - 8:15
Registration & Networking Breakfast in Exhibition Hall
_______________________________________________________________________________________
8:15 - 8:30
Chairpersons’ Opening Remarks (will occur within each separate track session)
_______________________________________________________________________________________
8:30 - 9:05
Participants may choose 1 of 4 concurrent tracks.
TRACK A
Consumer Empathy: How Panadol Turned to the Mind to Reveal New Opportunities to Strengthen
Its Relationship with Consumers
Elizabeth Latoracca
, Global Insights Director, GlaxoSmithKline

Panadol is a brand that is iconic in the minds of Australians and many others around the world. It is used by
grandparents, parents and children alike. However, like many long-standing brands, it is at risk of becoming
irrelevant in a market place that keeps changing with new threats, new regulations and new consumers.
Beginning in 2010, the brand had rarely reached normal levels of recognition and over the past three years
had only hit a normal level of recognition for one campaign while others were as low as only 20% of normal
recognition even after significant investment.

The team knew that it had to do something to maintain its prominence in the market place and solidify its
defense against new entrants. The team also knew it didn’t have a branding problem nor a creative problem.
The brand itself is well-known and loved by consumers and the creative was well planned and well executed.
The team realized it had an empathy problem – it didn’t truly understand its audience’s deeper emotions
related to pain, drivers of behavior in choosing a pain reliever and what was truly at risk when it came to pain
management.

The team’s solution: to establish a clear understanding of the consumer and to lead the team in developing a
deeper sense of consumer empathy. With this consumer empathy squarely in the minds of the brand team, the
creative briefs were updated and new more emotional campaign launched that immediately achieved normal
levels of recognition with only a fraction of the investment. Today, the brand’s health measures continue to
move in the right direction and they remain prepared for a changing market place.
_______________________________________________________________________________________
TRACK B
Topic TBA
Kantar Health
_______________________________________________________________________________________
TRACK C
Does (VUCA) Volatility, Uncertainty, Complexity and Ambiguity Make Strategic Planning Obsolete?
Heath Gross
, Managing Partner, Sedulo Group

Over the last two decades military strategists have had to make significant changes to their planning process
as they deal with the shift from linear battlefields to combating guerrilla warfare and terrorism. Leveraging the
VUCA framework, military strategists have overcome many of the challenges associated with Volatility,
Uncertainty, Complexity and Ambiguity.

In the private sector, corporations have experienced similar upheaval and uncertainty as innovative
technology, and the shift to a global economy, have dramatically increased the rate of change and the
propensity for disruption.

Leveraging Heath's experience in both military and corporate strategy, we will discuss the value of the VUCA
framework applied to business.  Particularly, we will focus on how competitive intelligence can support strategic
planning by minimizing the impact of Volatility, Uncertainty, Complexity and Ambiguity.
_______________________________________________________________________________________
TRACK D
Partnering for Insights
Amy Abel
, Senior Vice-President, Chief Commercial Officer, Adelphi Research
Carly Gibbons, Associate Director, Adelphi Research
Michelle Supsic, Senior Director, Adelphi Research
Ratna Wynn, Vice President, Adelphi Research
Client Co-Presenter TBA
_______________________________________________________________________________________
9:10 - 9:45
Participants may choose 1 of 4 concurrent tracks.
TRACK A
Emotional insights – Uncovering and Leveraging the Hidden Drivers of Customer Behavior
Richard Kaminsky
, Director International Customer Insight Manager, Boehringer Ingelheim

Rich will lead a discussion of CI (customer insights), with a view toward enhanced identification and practical
application, focusing on:
•        Customer-centric communication
•        Methodological and analytical design to optimize insights generation
•        Case study review from immunology, respiratory, metabolic and sexual health therapeutic areas
_______________________________________________________________________________________
TRACK B
Unlock Real World, Real Time Patient Informatics
Dr. Jared Adams
, MD, PhD, Chief Medical Officer, Director of Product Development, Self Care Catalysts Inc
Leslie Jamison, EVP, Managing Director, Self Care Catalysts Inc
Client Co-Presenter TBA
_______________________________________________________________________________________
TRACK C
Best Practices in Data Visualization, Dashboards & Analytics
Ganesh Kanumalla
, CEO, IQ 20/20
Client Co-Presenter TBA
_______________________________________________________________________________________
TRACK D
Ongoing Patient Collaboration Leads to Better Outcomes
Regina Mercado
, Senior Manager Marketing Analytics & Business Insights, AbbVie
Kevin O’Shea, Manager Marketing Analytics & Business Insights, AbbVie
Corey Schwartz, Managing Director, Communispace Health
_______________________________________________________________________________________
   
9:45 - 10:45
Networking & Refreshments in Exhibition Hall
_______________________________________________________________________________________
   
10:45 - 11:20
Participants may choose 1 of 4 concurrent tracks.
TRACK A
Topic TBA
Michael Devinoff
, Executive Director, Forecasting, Epidemiology, & Predictive Analytics, Bristol-Myers Squibb
Anthony Pugliese, Director, Customer Insights & Analytics, Bristol-Myers Squibb
_______________________________________________________________________________________
TRACK B
Gamification in Market Research
Anne Hale
, US Specialty Care Lead – Business Analytics & Insights, Pfizer
_______________________________________________________________________________________
TRACK C
Condoms and Car Restraints – Can We Learn Anything About Compliance?
Joel Schindler
, Vice President, MarketVision Research
_______________________________________________________________________________________
TRACK D
Topic TBA
Campbell Alliance
_______________________________________________________________________________________
   
11:25 - 12:15
Networking Roundtable Discussions
ROUNDTABLE 1
Opportunities in Global Market Research
Frank Wang
, Senior Director, Global Business Insights Oncology, EMD Serono
ROUNDTABLE 2
“Do It Yourself” Analytics
Wasse Alemayehu
, Director, Shire Pharmaceuticals
ROUNDTABLE 3
What Truly Drives Physicians Behavior Beyond Efficacy and Safety of the Products and How Does
One Go About Diving Deeper Behind the Veil?
Aaron Furtado
, Senior Director, Business Planning, Market Research, & Business Analytics, Ipsen
ROUNDTABLE 4
Topic TBA
John Vieira
, Sr. Director, Global Brand Strategy, Daiichi Sankyo
ROUNDTABLE 5
Challenges in Global Forecasting
Suraj Moorthy
, Senior Director, Global Forecasting, EMD Serono
ROUNDTABLE 6
Topic TBA
Carolyn Kreusser
, Associate Director, Auxilium
ROUNDTABLE 7
Topic TBA
Michael McClellan,
Associate Director, Global New Products Market Research, Eisai
ROUNDTABLE 8
TBA
   
12:15 - 1:25
Networking Luncheon
_______________________________________________________________________________________
General Session:
1:25 - 1:35
Announcement of "Exhibitor Passport" Grand Prize Winner & Other Raffle Prize Winners
_______________________________________________________________________________________
1:35 - 2:05
The Future of Market Research and Skill Sets Required for Future Market Researchers
Binita Bhattacharya
, Design Research Associate, BD Diagnostics
Rafaat Rahmani, President, Lifescience Dynamics Limited

•        Introduction and background
•        Current state of pharmaceutical & medical device market research in the USA and EU
•        How can the MR vendors deliver more to the Industry?
•        The way forward: MR vendor view
•        Challenges for the Industry and the MR vendors
•        The way forward: Industry view
•        Summary and takeaways
_____________________________________________________________________________
__________
2:05 - 2:35
Towards True Patient Centricity – The Pharma Odyssey
Peter Simpson
, Principal, Segmedica
_______________________________________________________________________________________
2:35 - 3:05
When You Need a Quick Read - Successful Approaches to Mobilizing Qual/Quant Insights at
High-Speed
David Scowcroft
, SVP, Ipsos Health
Client Co-Presenter TBA
_____________________________________________________________________________
__________
3:05 - 3:45
Summary and Key Takeaways By Advisory Board Members
Praveen Advani
, Executive Director, Customer Insights Oncology - IO, Bristol-Myers Squibb
Lisa Courtade, Executive Director, Global Market Research Excellence, Merck
Sandipa Dublish, Sr. Director Global MR, Alexion Pharmaceuticals
Steve Girling, President, Ipsos Healthcare
Stuart Greenberg, Deputy Director, Global/Oncology Market Research, Bayer
Anne Hale, US Specialty Care Lead – Business Analytics & Insights, Pfizer
Grace Samoil Reynolds, Head Market Insights, Celgene
David Rosen, Executive Director, Forecasting, Analytics & Market Research, Purdue Pharmaceuticals
_______________________________________________________________________________________
3:45
Conference Concludes
_______________________________________________________________________________________
   
Pre-Conference Workshops, Tuesday, February 3, 2015
[Separate Registration Required]
8:30 - 9:00
Registration and Networking Breakfast
_______________________________________________________________________________________
9:00 - 10:45
TBA
_______________________________________________________________________________________
10:45 - 11:00
Networking Break
_______________________________________________________________________________________
11:00 - 1:00
MR in the Context of Business Development and Licensing
Marianne Jaeger
, Ph.D., Methodologist, Lifescience Dynamics
Rafaat Rahmani, President, Lifescience Dynamics

•        How can MR support the BD&L process?
•        How can CI and payer discussions complement MR in this process?
•        How can MR, CI and Payer research input in the forecasting?
•        Valuation of an asset
_______________________________________________________________________________________
1:00 - 2:00
Networking Luncheon
_______________________________________________________________________________________
2:00 - 5:00
The Patient Journey Unplugged – An In-Depth and Interactive Workshop on How to Manage and
Get the Very Best Insights
Donna Simpson
, Principal, Segmedica
Peter Simpson, Principal, Segmedica
Michelle Soto, Senior Project Director, Segmedica
_____________________________________________________________________________________
3:30 - 3:45
Networking Break
_______________________________________________________________________________________
5:00
Pre-Conference Workshops Conclude
_______________________________________________________________________________________
February 4-5, 2015
Hilton Parsippany Hotel, Parsippany, NJ